NTLiverTac PDE6D degrader-1
NTLiverTac PDE6D degrader-1 is a PDE6D NTLiverTac degrader with a DC50 of 4.09 μM. NTLiverTac PDE6D degrader-1 is formed by conjugating a PDE6D PROTAC degrader with the NTCP ligand Cholic acid (HY-N0324). NTLiverTac PDE6D degrader-1 triggers the ubiquitin-proteasome system-mediated degradation process by forming a complex with PDE6D and MDM2, inducing proteasome-dependent and NTCP-dependent degradation. NTLiverTac PDE6D degrader-1 inhibits PDE6D-dependent KRAS trafficking and suppresses KRAS-related oncogenic signaling cascades. NTLiverTac PDE6D degrader-1 inhibits the activation of the PI3K/AKT/mTOR signaling pathway and induces cellular Apoptosis. NTLiverTac PDE6D degrader-1 enters cancer cells via NTCP-mediated endocytosis. NTLiverTac PDE6D degrader-1 can be used in the research of hepatoblastoma (MDM2 ligand: (4R,5S)-Nutlin carboxylic acid (HY-128836); NTCP ligand: Cholic acid (HY-N0324); PDE6D ligand: Sorafenib (HY-10201)).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C93H113Cl3F3N15O17
- 분자량:1876.34
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
제품 설명
IC50 & Target
[1]|
PDE6D 4.09 μM (DC50) |
K-RAS |
MDM2 |
In Vitro
NTLiverTac PDE6D degrader-1 (Compound S2C2M2) inhibits the proliferation of HuH-6 cells with an IC50 value of 7.46 μM[1].
NTLiverTac PDE6D degrader-1 (0.3-30 μM; 24-72 h) induces proteasome-dependent and NTCP-dependent degradation of PDE6D in HuH-6 cells, with a DC50 of 4.09 μM at 60 h[1].
NTLiverTac PDE6D degrader-1 (30 μM) inhibits the activation of KRAS in HuH-6 cells[1].
NTLiverTac PDE6D degrader-1 (3.75-30 μM) inhibits EGF-induced activation of the PI3K/AKT/mTOR signaling pathway in HuH-6 cells in a concentration-dependent manner[1].
NTLiverTac PDE6D degrader-1 (7.5-30 μM) induces apoptosis in HuH-6 cells in a concentration-dependent manner by regulating the levels of pro-apoptotic and anti-apoptotic proteins[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human hepatoblastoma HuH-6 cells
-
Concentration:0.3-30 μM (PDE6D degradation concentration-dependence); 30 μM (PDE6D degradation time-dependence); 30 μM (pre-treatment with 50 nM proteasome inhibitor MG132, 0.5 μM neddylation inhibitor MLN4924, 30 μM MDM2 ligand Nutlin 3a, 30 μM multikinase inhibitor sorafenib, 10 μM cholic acid, or 0.5 μM NTCP inhibitor bluevirtide)
-
Incubation Time:60 h (PDE6D degradation concentration-dependence); 24-72 h (PDE6D degradation time-dependence); 60 h (pre-treatment with inhibitors, with 4 h pre-treatment)
-
Result:Induced concentration-dependent PDE6D degradation, with a DC50 (60 h) of 4.09 μM, and reduced PDE6D protein levels by approximately 70% at 30 μM after 72 h.
Induced time-dependent PDE6D degradation, with decreasing protein levels over 72 h at 30 μM.
Blocked KRAS IN-44-mediated PDE6D degradation when cells were pre-treated with proteasome inhibitor MG132, neddylation inhibitor MLN4924, MDM2 ligand Nutlin 3a, multikinase inhibitor sorafenib, NTCP substrate cholic acid, or NTCP inhibitor bluevirtide.
Chemical Information
-
분자량 1876.34
-
화학식 C93H113Cl3F3N15O17
-
SMILES
ClC1=CC=C([C@@H]2[C@H](C3=CC=C(Cl)C=C3)N(C(N4CC(N(CC(NCCOCCOCCN5C=C(COCC(NC(CCNC(CC[C@@H](C)[C@]6([H])[C@]([C@@H](O)C[C@@]7([H])[C@@]8([H])[C@H](O)C[C@@]9([H])[C@]7(C)CC[C@@H](O)C9)(C)[C@@]8([H])CC6)=O)=O)C(NCCNC(C%10=NC=CC(OC%11=CC=C(NC(NC%12=CC=C(Cl)C(C(F)(F)F)=C%12)=O)C=C%11)=C%10)=O)=O)N=N5)=O)CC4)=O)=O)C(C%13=CC=C(OC)C=C%13OC(C)C)=N2)C=C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)